Cita APA

Makii, C., Oda, K., Ikeda, Y., Sone, K., Hasegawa, K., Uehara, Y., . . . Fujii, T. (2016). MDM2 is a potential therapeutic target and prognostic factor for ovarian clear cell carcinomas with wild type TP53. Oncotarget.

Chicago Style Citation

Makii, Chinami, et al. "MDM2 Is a Potential Therapeutic Target and Prognostic Factor for Ovarian Clear Cell Carcinomas With Wild Type TP53." Oncotarget 2016.

Cita MLA

Makii, Chinami, et al. "MDM2 Is a Potential Therapeutic Target and Prognostic Factor for Ovarian Clear Cell Carcinomas With Wild Type TP53." Oncotarget 2016.